Mayo Clinic: Pancreatitis trials
The registry lists 12 Pancreatitis studies with Mayo Clinic as lead sponsor. 3 are open to participants now and 3 have results posted.
Early Phase 1 1Phase 1 3Phase 2 3Phase 3 1Phase 4 1No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Varenicline for Smoking Cessation in PancreatitisNot yet recruitingNCT07874841Phase 4
- Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis/Acute Pancreatitis Associated Diabetes MellitusRecruitingNCT06729996Phase 2
- Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic DisordersRecruitingNCT00830557
- Trial of Indomethacin in Chronic PancreatitisCompletedNCT04207060Phase 1/2Results posted
- Pentoxifylline Treatment in Acute Pancreatitis (AP)CompletedNCT02487225Phase 3Results posted
- Pentoxifylline Treatment of Acute PancreatitisCompletedNCT01292005Early Phase 1Results posted
- Smoking Cessation Trial in Recurrent Acute Pancreatitis and Chronic PancreatitisWithdrawnNCT07171112Phase 2
- Treating Acute Pancreatitis With Dabigatran, a Pilot StudyTerminatedNCT03807856Phase 1
- Treatment of IgG4-Related Disease With Revlimid and RituximabCompletedNCT02705638Phase 1
- Endoscopic Large Caliber Drainage vs. Complete Necrosectomy for Treatment of Walled-off Pancreatic NecrosisWithdrawnNCT02564965Not applicable
- Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic CancerCompletedNCT00851955
- CT Pancreas PerfusionCompletedNCT00588367